Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.
Rom J Intern Med. 2013.
PMID: 24620626